GlassScriptPhysician profile
Mitchell C Fraiman
NPI 1417931189
$3,879.72
in general payments reported to CMS, 2019-2025
30 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $287 · 2021: $539 · 2022: $162 · 2023: $43.47 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Travel and Lodging: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.26 |
| Travel and Lodging | $841.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,190.53 | 2025 | |
| Astellas Pharma US INC | $602.05 | 2019-2025 | Xtandi |
| Koelis INC. | $357.85 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $153.91 | 2019-2023 | |
| Pfizer INC. | $153.39 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $136.25 | 2019-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $132.93 | 2025 | Orgovyx |
| Janssen Biotech, INC. | $109.72 | 2019-2025 | Erleada |
| Allergan, INC. | $101.57 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $89.84 | 2025 | |
| Antares Pharma, INC. | $89.14 | 2019-2021 | |
| Urogen Pharma, INC. | $82.15 | 2022-2023 | Jelmyto |
| Edap Technomed INC | $76.01 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $64.10 | 2019 | |
| Boston Scientific Corporation | $63.75 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $57.30 | 2019-2020 | |
| Myovant Sciences INC. | $57.02 | 2021 | |
| Endo USA, INC. | $53.09 | 2025 | Xiaflex, Aveed |
| Coloplast Corp | $48.50 | 2019-2025 | |
| Calyxo, INC. | $31.78 | 2025 | Cvac Aspiration System |
| Amgen INC. | $28.04 | 2019 | |
| Abbvie INC. | $27.64 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $27.30 | 2019 | |
| Dentsply Ih Ab | $25.82 | 2025 | Lofric |
| Teleflex LLC | $24.15 | 2025 | Barrigel |
| Abc Home Medical Supply, INC. | $23.98 | 2025 | |
| Bioprotect Medical, INC. | $20.85 | 2025 | Bioprotect Balloon Implant System |
| Blue Earth Diagnostics | $19.88 | 2021 | |
| Myriad Genetic Laboratories, INC. | $19.62 | 2025 | Prolaris |
| Dentsply Ih INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Fraiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.